Table 1.
Prequit baseline demographics by group.
Delayed Quit | Placebo | Bupropion SR | NRT | |||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Comp. 18 | Drops 02 | Abstain 25 | Relapse 10 | Abstain 24 | Relapse 10 | Abstain 28 | Relapse 10 | |
Age | 27.2 (10.9) |
23.0 (4.2) |
32.8 (11.5) |
28.2 (6.7) |
32.8 (12.4) |
28.2 (10.1) |
31.5 (11.3) |
28.2 (10.1) |
Gender | 10M, 8F | 2M, 0F | 13M, 12F | 4M, 6F | 14M, 10F | 6M, 4F | 16M, 12F | 4M, 6F |
Ethnicity | AA-1 AI-0 Asn-1 Cau-14 Other-2 |
AA-0 AI-0 Asn-0 Cau-2 Other-0 |
AA-0 AI-0 Asn-1 Cau-24 Other-0 |
AA-0 AI-0 Asn-0 Cau-10 Other-0 |
AA-2 AI-0 Asn-0 Cau-19 Other-3 |
AA-1 AI-1 As-0 Cau-8 Other-0 |
AA-0 AI-0 Asn-0 Cau-27 Other-1 |
AA-1 AI-0 Asn-0 Cau-9 Other-0 |
Hispanic | 1 | 0 | 2 | 0 | 1 | 0 | 1 | 1 |
Education | 3.78 (1.35) |
3.50 (0.71) |
4.32 (1.46) |
3.50 (0.85) |
4.00 (1.77) |
3.40 (1.75) |
3.82 (1.52) |
3.40 (1.43) |
Age first smoked daily* | 18.28 (4.23) |
15.00 (4.24) |
17.84 (2.59) |
17.40 (2.17) |
17.75 (3.47) |
16.20 (1.75) |
17.68 (3.33) |
15.3 (2.75) |
FTND | 3.78 (2.34) |
4.50 (0.71) |
3.44 (1.94) |
5.50 (1.72) |
4.29 (1.14) |
4.50 (2.42) |
4.25 (2.19) |
4.10 (1.79) |
CPD | 18.06 (6.38) |
16.00 (4.25) |
16.56 (6.04) |
20.70 (1.90) |
19.25 (9.23) |
15.5 (4.97) |
17.79 (7.18) |
17.50 (5.48) |
Cotinine | 5.86 (.41) |
6.0 (0.0) |
5.92 (.28) |
6.0 (.0) |
6.0 (.0) |
6.0 (.0) |
5.95 (.21) |
6.0 (.0) |
Hx of Depress. | 1 | 1 | 6 | 4 | 7 | 0 | 8 | 3 |
Hx of Anxiety Disorder | 5 | 1 | 5 | 2 | 5 | 1 | 10 | 3 |
Hx of PTSD | 5 | 0 | 4 | 3 | 3 | 0 | 8 | 2 |
Note. Means, standard deviations (in parentheses), and Counts: Education: 1= HS equivalency exam, 2=Completed HS, 3= Some College, 4=Associates degree; 5=4-yr degree; 6=Some Grad school; 7=Completed Grad School. Cotinine: 4= 200–500 ng/ml, 5 = 500–1000 ng/ml and 6 = over 1000 ng/ml urine concentrations. Ethnicity (self-reported): AA = African American, AI= American Indian, Asn=Asian, Cau = Caucasian, Oth = Other or mixed.
p <.05 completers = older age of daily smoking onset than relapsers. Hx = history of SCID-assessed major depressive disorder, anxiety disorder, or post-traumatic stress disorder.